Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 28;14(21):4556.
doi: 10.3390/nu14214556.

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review

Kiarash Riazi  1   2 , Mark G Swain  1 , Stephen E Congly  1 , Gilaad G Kaplan  1   2   3 , Abdel-Aziz Shaheen  1   2   3
Affiliations
Review

Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review

Kiarash Riazi et al. Nutrients. .

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a significant public health concern worldwide with a complex etiology attributed to behavioural, environmental, and genetic causes. The worldwide prevalence of NAFLD is estimated to be 32.4% and constantly rising. Global data, however, indicate considerable heterogeneity among studies for both NAFLD prevalence and incidence. Identifying variables that affect the estimated epidemiological measures is essential to all stakeholders, including patients, researchers, healthcare providers, and policymakers. Besides helping with the research on disease etiology, it helps to identify individuals at risk of the disease, which in turn will outline the focus of the preventive measures and help to fittingly tailor individualized treatments, targeted prevention, screening, or treatment programs. Several studies suggest differences in the prevalence and severity of NAFLD by race or ethnicity, which may be linked to differences in lifestyle, diet, metabolic comorbidity profile, and genetic background, among others. Race/ethnicity research is essential as it can provide valuable information regarding biological and genetic differences among people with similar cultural, dietary, and geographical backgrounds. In this review, we examined the existing literature on race/ethnicity differences in susceptibility to NAFLD and discussed the contributing variables to such differences, including diet and physical activity, the comorbidity profile, and genetic susceptibility. We also reviewed the limitations of race/ethnicity studies in NAFLD.

Keywords: diet; genetic predisposition to disease; non-alcoholic fatty liver disease; population groups; prevalence; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Simple representation of the topics discussed in this review. PNPLA3 (Patatin-like phospholipase domain-containing protein 3), HTN (Hypertension), T2DM (Type 2 Diabetes Mellitus), NAFLD (Non-alcoholic Fatty Liver Disease).
See this image and copyright information in PMC

References

    1. Riazi K., Raman M., Taylor L., Swain M.G., Shaheen A.A. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer? Nutrients. 2019;11:2878. doi: 10.3390/nu11122878. - DOI - PMC - PubMed
    1. Fotbolcu H., Zorlu E. Nonalcoholic fatty liver disease as a multi-systemic disease. World J. Gastroenterol. 2016;22:4079–4090. doi: 10.3748/wjg.v22.i16.4079. - DOI - PMC - PubMed
    1. Fahed G., Aoun L., Zerdan M.B., Allam S., Zerdan M.B., Bouferraa Y., Assi H.I. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022;23:786. doi: 10.3390/ijms23020786. - DOI - PMC - PubMed
    1. Godoy-Matos A.F., Silva Júnior W.S., Valerio C.M. NAFLD as a continuum: From obesity to metabolic syndrome and diabetes. Diabetol. Metab. Syndr. 2020;12:60. doi: 10.1186/s13098-020-00570-y. - DOI - PMC - PubMed
    1. Estes C., Razavi H., Loomba R., Younossi Z., Sanyal A.J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123–133. doi: 10.1002/hep.29466. - DOI - PMC - PubMed